Kerri Burson

Kerri Burson is an experienced regulatory affairs professional specializing in Chemistry, Manufacturing, and Controls (CMC). Currently serving as the Director of Regulatory Affairs CMC at Intellia Therapeutics, Inc. since May 2023, Kerri previously held the position of Director of Regulatory Affairs CMC at eGenesis, Inc. from October 2022 to May 2023. Prior to that, Kerri was with REGENXBIO Inc., where roles included Associate Director and Senior Manager of Regulatory Affairs CMC from 2020 to October 2022, as well as Manager of Regulatory Affairs CMC from 2017 to 2019. Kerri holds a Master’s degree in Biological Sciences from Washington University in St. Louis and a Bachelor’s degree in Biology with minors in Chemistry and Physical Sciences from Pittsburg State University.